Actinium Pharmaceuticals Inc (ATNM) — Cash Flow Reinvestment Rate
Actinium Pharmaceuticals Inc (ATNM) has a Cash Flow Reinvestment Rate of 0.02x as of June 2022, reinvesting $540.00K (capex $270.00K plus investments $-270.00K) from operating cash flow of $27.92 Million. Check ATNM cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Actinium Pharmaceuticals Inc Cash Flow Reinvestment Rate (2010–2022)
Historical reinvestment intensity for Actinium Pharmaceuticals Inc across 3 annual periods. Explore Actinium Pharmaceuticals Inc (ATNM) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Actinium Pharmaceuticals Inc (2010–2022)
Year-by-year capital reinvestment analysis for Actinium Pharmaceuticals Inc. For live market cap and broader valuation context, see ATNM company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.08x | $732.00K | $8.64 Million | $366.00K | — |
| 2011 | 0.00x | $0.00 | $539.00 | $0.00 | — |
| 2010 | 0.00x | $0.00 | $7.83K | $0.00 | — |